Abstract WP312: Rosiglitazone Ameliorates Tissue Plasminogen Activator-Induced Hemorrhagic Transformation After Stroke via Promoting Phagocytic Activity of Microglia

Objective: Delayed thrombolytic treatment with recombinant tissue plasminogen activator (tPA) may lead to lethal hemorrhagic transformation (HT) after ischemic stroke. Rosiglitazone(RSG) is one of ...